Literature DB >> 15883474

Mutations in MODY genes are not common cause of early-onset type 2 diabetes in Mexican families.

Aarón Domínguez-López1, Angel Miliar-García, Yayoi X Segura-Kato, Laura Riba, Riba Esparza-López, Salvador Ramírez-Jiménez, Maribel Rodríguez-Torres, Samuel Canizales-Quinteros, Siraam Cabrera-Vásquez, Verónica Fragoso-Ontiveros, Carlos A Aguilar-Salinas, Nelly Altamirano-Bustamante, Raúl Calzada-León, Carlos Robles-Valdés, Luz E Bravo-Ríos, Maria Teresa Tusié-Luna.   

Abstract

CONTEXT: Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes mellitus characterized by autosomal dominant inheritance, early age of onset and a primary insulin secretion defect. Certain MODY gene sequence variants may be involved in polygenic forms of type 2 diabetes.
OBJECTIVE: We assessed the contribution of MODY genes to the etiology of type 2 early-onset diabetes in 23 Mexican families, including five with apparently autosomal dominant inheritance. PATIENTS: Twenty-three unrelated Mexican families with early-onset type 2 diabetes previously screened for the presence of glucokinase mutations, were studied.
DESIGN: We screened MODY genes for sequence variants by PCR-SSCP analysis and automated sequencing. We performed a functional analysis of the HNF-1alpha P379H recombinant protein in vitro in both HeLa and RINm5f beta-cell lines. MAIN OUTCOME MEASURES: MODY gene mutation screening and P379H mutant protein transactivation assay.
RESULTS: No mutations were detected in the HNF-4alpha, IPF-1, NEUROD1 or HNF-1beta genes in any of the families studied. A new mutation (P379H) of the HNF-1alpha gene was identified in one MODY family. RINm5f and HeLa cell transfection assays revealed decreased transactivation activity of the mutant protein on the human insulin promoter.
CONCLUSIONS: All known MODY genes were screened for abnormalities in this cohort of early-onset diabetes families which included 5 MODY pedigrees. We identified a new HNF-1alpha MODY mutation (P379H) and demonstrated that it reduces the transactivation potential of the mutant protein on the human insulin promoter. No other mutation was identified in this cohort indicating that abnormalities in MODY genes are generally not a common cause of early-onset diabetes and this includes MODY families in Mexico.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883474

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  7 in total

1.  Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism.

Authors:  James T Bennett; Valeria Vasta; Min Zhang; Jaya Narayanan; Peter Gerrits; Si Houn Hahn
Journal:  Mol Genet Metab       Date:  2014-12-20       Impact factor: 4.797

2.  Clinically-Defined Maturity Onset Diabetes of the Young in Omanis: Absence of the common Caucasian gene mutations.

Authors:  Nicholas Jy Woodhouse; Omayma T Elshafie; Ali S Al-Mamari; Nagi Hs Mohammed; Fatma Al-Riyami; Sandy Raeburn
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

3.  Examination of Rare Variants in HNF4 α in European Americans with Type 2 Diabetes.

Authors:  Jacklyn N Hellwege; Pamela J Hicks; Nicholette D Palmer; Maggie C Y Ng; Barry I Freedman; Donald W Bowden
Journal:  J Diabetes Metab       Date:  2011-10-20

4.  Mutations in HNF1A Gene are not a Common Cause of Familial Young-Onset Diabetes in Iran.

Authors:  Meysam Moghbeli; Bahram Naghibzadeh; Martha Ghahraman; Sedigheh Fatemi; Morteza Taghavi; Rahim Vakili; Mohammad Reza Abbaszadegan
Journal:  Indian J Clin Biochem       Date:  2017-04-13

Review 5.  Undiagnosed MODY: Time for Action.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

6.  Mutations in the coding regions of the hepatocyte nuclear factor 4 alpha in Iranian families with maturity onset diabetes of the young.

Authors:  Seyed Morteza Taghavi; Seyedeh Seddigheh Fatemi; Houshang Rafatpanah; Rashin Ganjali; Jalil Tavakolafshari; Narges Valizadeh
Journal:  Cardiovasc Diabetol       Date:  2009-12-10       Impact factor: 9.951

7.  Differentiating Among Type 1, Type 2 Diabetes, and MODY: Raising Awareness About the Clinical Implementation of Genetic Testing in Latin America.

Authors:  Lam-Chung César Ernesto; Elizondo Ochoa Álvaro; Segura Kato Yayoi; Silva-Serrano Juanita; Tusié Luna María Teresa; Paloma Almeda-Valdes
Journal:  AACE Clin Case Rep       Date:  2020-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.